These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3630484)

  • 21. Monoclonal antibodies against the enzymatic subunit of both pertussis and cholera toxins.
    Kenimer JG; Probst PG; Karpas AB; Burns DL; Kaslow HR
    Dev Biol Stand; 1991; 73():133-41. PubMed ID: 1778307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic interactions between human transfected adenosine A1 receptors and endogenous cholecystokinin receptors in CHO cells.
    Dickenson JM; Hill SJ
    Eur J Pharmacol; 1996 Apr; 302(1-3):141-51. PubMed ID: 8791002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells.
    Millen SH; Bernstein DI; Connelly B; Ward JI; Chang SJ; Weiss AA
    Infect Immun; 2004 Jan; 72(1):615-20. PubMed ID: 14688147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in intradermal vascular permeability caused by pertussis toxin from Bordetella pertussis.
    Sakuma S; Imagawa Y; Tokunaga E; Ohtomo N
    Microbiol Immunol; 1987; 31(6):531-9. PubMed ID: 2890084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of neutralising human recombinant antibodies to pertussis toxin.
    Williamson P; Matthews R
    FEMS Immunol Med Microbiol; 1999 Apr; 23(4):313-9. PubMed ID: 10225291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Purification and properties of Bordetella pertussis toxin].
    Gureeva AA; Grigorian GIu; Rybin VO; Pereverzev NA; Lapaeva IA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):32-7. PubMed ID: 3529763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of purified components of Bordetella pertussis in the weight gain test for the toxicity testing of pertussis vaccines.
    Redhead K; Seagroatt V
    J Biol Stand; 1986 Jan; 14(1):57-65. PubMed ID: 2870067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coupling of muscarinic m1, m2 and m3 acetylcholine receptors, expressed in Chinese hamster ovary cells, to pertussis toxin-sensitive/insensitive guanine nucleotide-binding proteins.
    Burford NT; Tobin AB; Nahorski SR
    Eur J Pharmacol; 1995 Apr; 289(2):343-51. PubMed ID: 7621908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of the biological properties of a cell-free pertussis preparation].
    Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Shmeleva EI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):38-43. PubMed ID: 2888247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Features of expression of the pertussis toxin operon under the control of its own and heterologous promotors in Bordetella bronchiseptica cells].
    Govorun VM; Ivanova VF; Kirillov MIu; Klitsunova NV; Nechaeva EV; Siniashina LN; Shumakov IuL; Karataev GI
    Mol Gen Mikrobiol Virusol; 1993; (2):21-7. PubMed ID: 8515746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of human monoclonal antibodies that confer protection against pertussis toxin.
    Zaccolo M; Roggero S; Armellini D; Pegoraro L; Rappuoli R; Malavasi F
    Infect Immun; 1992 Mar; 60(3):1258-60. PubMed ID: 1541543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of pertussis toxin correlates with pathogenesis in Bordetella species.
    Monack D; Munoz JJ; Peacock MG; Black WJ; Falkow S
    J Infect Dis; 1989 Feb; 159(2):205-10. PubMed ID: 2464653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune suppression and induction of gamma interferon by pertussis toxin.
    Vogel FR; Klein TW; Stewart WE; Igarashi T; Friedman H
    Infect Immun; 1985 Jul; 49(1):90-7. PubMed ID: 3924834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Humoral response to the injection of acellular Pertussis vaccine].
    Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutants of pertussis toxin suitable for vaccine development.
    Pizza M; Covacci A; Bartoloni A; Perugini M; Nencioni L; De Magistris MT; Villa L; Nucci D; Manetti R; Bugnoli M
    Science; 1989 Oct; 246(4929):497-500. PubMed ID: 2683073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and potency of an acellular pertussis vaccine composed of pertussis toxin, filamentous hemagglutinin, and pertactin.
    Sheu GC; Wo YY; Yao SM; Chou FY; Hsu TC; Ju CL; Cheng Y; Chang SN; Lu CH
    J Microbiol Immunol Infect; 2001 Dec; 34(4):243-51. PubMed ID: 11825003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hamster alpha 1B-adrenergic receptor directly activates Gs in the transfected Chinese hamster ovary cells.
    Horie K; Itoh H; Tsujimoto G
    Mol Pharmacol; 1995 Sep; 48(3):392-400. PubMed ID: 7565618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
    Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE
    J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for pertussis toxin--Part 1.
    Dobbelaer R; Daas A; Esposito-Farese ME
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):15-23. PubMed ID: 11705098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.